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Background: Suggestions of an increased
asthma risk associated with swimming pool
attendance have been made but evidence is
conflicting. We aimed to assess the impact
of swimming pool attendance on lung
function, airway inflammation, and risk of
asthma and allergic diseases in Portuguese
school aged children.
Method: A cross-sectional survey in 348
children, aged 7–12 years, from 10 primary
schools in Porto, was carried out from Jan-
uary to June 2014. Parents completed a
questionnaire on demographics, environ-
mental exposure, espiratory health and
participants had lung function assessed by
spirometry, airway inflammation by
exhaled nitric oxide and atopy by skin
prick tests. Final analysis included 269
children, aged 8.8  0.9 years, 144 girls.
The association between current swimming
and health outcomes was evaluated using
multivariate logistic regression models or
chi-square test were appropriate.
Results: No differences in prevalence of
atopy (34% vs. 40%; P = 0.471), asthma
(15% vs. 7%; P = 0.062); allergic rhinitis
(15% vs. 19%; P = 0.509), and eczema/der-
matitis (18% vs. 11%; P = 0.542) were
observed between current swimmers
(n = 53; 3.1  2.8 h/week/year of swim-
ming pool cumulative exposure) and others
(n = 216). Lung function parameters (FVC,
FEV1, FEF2575) were similar but signifi-
cant differences in exhaled nitric oxide
levels were observed (mean 95%CI:
24.9 ppb (15.7 to 34.2) vs. 14.7 ppb (12.0
to 17.5); P = 0.004) after adjustment for
atopy, height, weight and age, between cur-
rent swimmers and others. Increased levels
of exhaled nitric oxide remained significant
even after excluding subjects with asthma
from the analysis (mean 95%CI: 18.0 ppb
(12.5 to 23.6) vs. 13.7 ppb (12.0 to 15.5);
P = 0.018).
Conclusion: The findings of our study are
limited by its cross sectional nature and
dot not allow us to establish causal rela-
tionships. Nevertheless, swimming pool
attendance was associated with non-patho-
logical increased levels of airway inflamma-
tion assessed by exhaled nitric oxide
independently of the presence of asthma.
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Background: The gold standard for evi-
dence-based medicine is a randomized clin-
ical trial, but it has a number of
shortcomings and it results do not reflect
the real-world clinical practice fully. When
conducting of RCT is difficult for various
reasons, to determine the effectiveness and
safety of any medical intervention in real-
life settings in terms of long-term observa-
tions, the information database of clinical
cases – patient registries are used.
In terms of the heterogeneity of clinical
symptoms in different groups of patients
with bronchial asthma (BA) the usage of
long-term clinical monitoring is optimal
for assessment of the efficacy and safety of
treatment of severe persistent uncontrolled
asthma in the real practice.
Aim: The creation of the patient registry
of children with severe persistent uncon-
trolled asthma.
Methods: Experts of the centre were estab-
lished software product – management
shell database of clinical cases – patient
registry of children with severe persistent
uncontrolled BA, one of the drugs for
basic treatment was Omalizumab.
Results: The database includes the clinical
information about 65 children (63% boys)
from 6 to 17 years 11 months (mean age
13.8 years) with severe persistent uncon-
trolled BA, whom have received / are
receiving (32 patients, 71.8% boys) bio-
engineered treatment of Omalizumab (du-
ration of treatment from 1 till 72 month).
During the analysed period of treatment
confirmed the safety of this medication:
have conducted more than 5390 injections,
local adverse events have occurred at a fre-
quency of 1/100–1/200 and manifested as a
light redness and induration, which had
cropped off 1–1.5 days after administra-
tion; local allergic reactions such as rashes
have occurred in two patients and have
treated with second generation antihistami-
nes and then will not be disturbed.
Conclusion: The patient registry is the
important tool for solving epidemiological
gaps in order to achieve optimal endpoints
for monitoring and analysis of the efficacy
and safety of innovative treatments and
approaches that have been used at long.
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Background: Chlamydophila pneumoniae
(CP) infection is a frequent cause of acute
respiratory infections, particularly in older
children and young adults. CP infection
may promote the exacerbation of asth-
matic symptoms but also may evolve into
chronic, asymptomatic phase, which some
researchers link with asthma pathogenesis
[1, 2]. CP potential role in asthma has been
divided into three different aspects: asthma
initiation, asthma prolongation, and
asthma exacerbation [3]. Data regarding
the CP role in children0s asthma control
are limited.
Method: Specific IgA, IgM, and IgG anti-
bodies to Chlamydophila pneumoniae were
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